MFS
AKBA icon

MSI Financial Services’s Akebia Therapeutics AKBA Stock Holding History

MSI Financial Services’s Portfolio AKBA Stock Details AKBA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$2K Hold
200
– – ﹤0.01% 3457
2016
Q3 		$2K Hold
200
– – ﹤0.01% 3458
2016
Q2 		$1K Hold
200
– – ﹤0.01% 3659
2016
Q1 		$2K Hold
200
– – ﹤0.01% 3489
2015
Q4 		$3K Buy
+200
New +$2.04K ﹤0.01% 3271

Other funds holding AKBA

EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return

MSI Financial Services's AKBA Position: Q4 2016 in Review

MSI Financial Services held its Akebia Therapeutics (AKBA) position steady in Q4 2016 at 200 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #3457.

MSI Financial Services first reported a position in AKBA in Q4 2015 and has held it in 5 quarters since. The position peaked at $3K in Q4 2015. 95 funds tracked by Wall St. Rank hold AKBA as of Q4 2016.

  • MSI Financial Services held 200 shares of Akebia Therapeutics worth $2K as of Q4 2016.
  • MSI Financial Services left its Akebia Therapeutics share count unchanged in Q4 2016.
  • Akebia Therapeutics made up ﹤0.01% of MSI Financial Services's portfolio in Q4 2016, its #3457 holding.
  • MSI Financial Services first reported a position in Akebia Therapeutics in Q4 2015 and has held it in 5 quarters since.
  • MSI Financial Services's Akebia Therapeutics position peaked at $3K in Q4 2015.
  • 95 funds tracked by Wall St. Rank held Akebia Therapeutics as of Q4 2016.

Based on MSI Financial Services's 13F filing for Q4 2016, filed 13 Jan 2017.